查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲尿道填充系統市場 - 產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按最終用戶、按國家：（歐洲）
市場調查報告書
商品編碼
1398756

歐洲尿道填充系統市場 - 產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按最終用戶、按國家：（歐洲）

Europe Urethral Bulking Systems Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (Europe)
出版日期: | 出版商: Fairfield Market Research | 英文 181 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

歐洲尿道填充系統市場規模預計將顯著成長，營收預計將從 2024 年的 2,500 萬美元增至 2031 年底的約 4,200 萬美元。

尿道膨脹系統用於治療壓力性尿失禁，這種尿失禁會導致女性感到羞恥和不適，尤其是在社交場合。 包括世界衛生組織 (WHO) 和醫療保健組織在內的各種組織正在努力提高對女性壓力性尿失禁的認識，並提高對現有治療方案的接受度。

壓力性尿失禁在孕婦中普遍存在，影響她們的生活品質。 許多國家的政府正在積極提高人們對女性壓力性尿失禁的認識，導致尿道膨脹系統的銷售增加。 懷孕率上升是壓力性尿失禁的主要風險因素，政府的資助預計將推動市場成長。

老年女性數量的快速增加是導致壓力性尿失禁盛行率上升的重要因素。 人口老化與壓力性尿失禁病例的增加密切相關。

壓力性尿失禁患者有多種治療選擇，包括手術、藥物、導尿、神經刺激和使用設備。 失禁護理產品等替代品的出現可能會限制尿道膨脹系統市場。

已有通報與尿道膨脹相關的嚴重副作用，例如尿道下膿瘍、尿道脫垂和顆粒遷移。 這些併發症對尿道膨脹系統的廣泛使用提出了挑戰。

本報告調查了歐洲尿道膨脹系統市場，並提供了市場概述，包括按產品、最終用戶、國家/地區劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第 3 章歐洲尿道填充系統市場前景，2018-2031

  • 2018-2031 年歐洲尿道填充系統市場前景（按產品、價值（百萬美元））
  • 2018-2031 年歐洲尿道膨脹系統市場前景（按最終用戶劃分）價值（百萬美元）
  • 2018-2031 年歐洲尿道膨脹系統市場前景（按國家/地區劃分）、價值（百萬美元）

第四章競爭態勢

  • 產品和最終用戶熱圖
  • 製造商和最終用戶的熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Boston Scientific Corporation
    • Coloplast Corporation
    • Axonics Modulation Technologies, Inc. (Contura, Inc.)
    • Palette Life Sciences, Inc.
    • Laborie, Inc.

第五章附錄

簡介目錄

The Europe Urethral Bulking Systems Market is set to experience substantial growth, with revenue expected to increase from US$ 25 million in 2024 to approximately US$ 42 million by the end of 2031, according to the latest market analysis by Fairfield Market Research.

Understanding Urethral Bulking Systems

Urethral bulking systems are used to treat stress urinary incontinence, a condition that affects women and can cause embarrassment and discomfort, particularly in social settings. Various organizations, including the World Health Organization and healthcare groups, have worked to raise awareness about female stress urinary incontinence, increasing the acceptance of available treatment options.

Key Market Drivers

High Pregnancy Rate and Government Support: Stress urinary incontinence is prevalent among pregnant women, impacting their quality of life. Governments in many countries are actively promoting awareness about female stress urinary incontinence, leading to increased sales of urethral bulking systems. The rising pregnancy rate, a key risk factor for stress urinary incontinence, and government funding are expected to drive market growth.

Growing Geriatric Population: The rapid increase in the number of elderly women is a significant factor contributing to the rising prevalence of stress urinary incontinence. Aging is closely linked to an increase in stress urinary incontinence cases.

Awareness Initiatives: Several companies are actively engaged in raising awareness of incontinence and providing educational programs to healthcare workers and the general public. These initiatives aim to enhance understanding of urological problems, their causes, risk factors, and treatment options.

Market Challenges

Presence of Alternatives: Patients with stress urinary incontinence have various treatment options, including surgery, medication, catheterization, nerve stimulation, or device use. The availability of alternatives like incontinence care products may restrain the urethral bulking systems market.

Complications Associated with Urethral Bulking Systems: There have been reported cases of severe side effects associated with urethral bulking, including suburethral abscess, urethral prolapse, and particle migration. These complications pose challenges to the adoption of urethral bulking systems.

Market Insights for Germany

The German market is experiencing growth due to the increasing incidence of urethral incontinence in females. Key contributing factors include menopause, hysterectomy, pregnancy, childbirth, and changing lifestyles.

Outlook for the UK Market

In the UK, 24% of the female population is estimated to be affected by stress incontinence, according to the National Institute for Health and Care Excellence (NICE). This makes the UK a potentially lucrative market for manufacturers.

Competitive Landscape

Mergers and acquisitions have become primary growth strategies in the European urethral bulking systems market. Leading manufacturers are expanding their product lines through acquisitions and targeting both established and emerging markets. Key players are also focusing on growth, new product launches, and expanding their sales channels, including online sales.

Market Segmentation

Product:

  • Pyrolytic carbon-coated graphite beads
  • Calcium Hydroxylapatite Based
  • Polydimethylsiloxane macroparticle
  • Polyacrylamide hydrogel
  • Hyaluronic Acid Based

End User:

  • Hospitals
  • Ambulatory Surgical centers
  • Specialty Clinic

Country:

  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Benelux
  • Nordic Countries
  • Rest of Europe

Table of Contents

1. Executive Summary

  • 1.1. Europe Urethral Bulking Systems Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Europe Urethral Bulking Systems Market Outlook, 2018 - 2031

  • 3.1. Europe Urethral Bulking Systems Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Pyrolytic carbon-coated graphite beads
      • 3.1.1.2. Calcium Hydroxylapatite based
      • 3.1.1.3. Polydimethylsiloxane macroparticle
      • 3.1.1.4. Polyacrylamide hydrogel
      • 3.1.1.5. Hyaluronic Acid Based
  • 3.2. Europe Urethral Bulking Systems Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Ambulatory Surgical centers
      • 3.2.1.3. Specialty Clinic
  • 3.3. Europe Urethral Bulking Systems Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Germany Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.2. Germany Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.3. U.K. Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.4. U.K. Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.5. France Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.6. France Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.7. Italy Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.8. Italy Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.9. Turkey Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.10. Turkey Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.11. Russia Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.12. Russia Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.13. Rest of Europe Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.14. Rest of Europe Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
    • 3.3.2. BPS Analysis/Market Attractiveness Analysis

4. Competitive Landscape

  • 4.1. Product vs End User Heatmap
  • 4.2. Manufacturer vs End User Heatmap
  • 4.3. Company Market Share Analysis, 2023
  • 4.4. Competitive Dashboard
  • 4.5. Company Profiles
    • 4.5.1. Boston Scientific Corporation
      • 4.5.1.1. Company Overview
      • 4.5.1.2. Product Portfolio
      • 4.5.1.3. Financial Overview
      • 4.5.1.4. Business Strategies and Development
    • 4.5.2. Coloplast Corporation
      • 4.5.2.1. Company Overview
      • 4.5.2.2. Product Portfolio
      • 4.5.2.3. Financial Overview
      • 4.5.2.4. Business Strategies and Development
    • 4.5.3. Axonics Modulation Technologies, Inc. (Contura, Inc.)
      • 4.5.3.1. Company Overview
      • 4.5.3.2. Product Portfolio
      • 4.5.3.3. Financial Overview
      • 4.5.3.4. Business Strategies and Development
    • 4.5.4. Palette Life Sciences, Inc.
      • 4.5.4.1. Company Overview
      • 4.5.4.2. Product Portfolio
      • 4.5.4.3. Financial Overview
      • 4.5.4.4. Business Strategies and Development
    • 4.5.5. Laborie, Inc.
      • 4.5.5.1. Company Overview
      • 4.5.5.2. Product Portfolio
      • 4.5.5.3. Financial Overview
      • 4.5.5.4. Business Strategies and Development

5. Appendix

  • 5.1. Research Methodology
  • 5.2. Report Assumptions
  • 5.3. Acronyms and Abbreviations